(NASDAQ:EXAS) SVP Sells $85134.64 in Stock

The consensus rating is 1.9, indicating analysts in general look favorably on the company's future prospects. EXACT Sciences Co. has a twelve month low of $23.30 and a twelve month high of $63.60. Currently, the stock is trading -45.58% ahead of its 52-week high and 49.09% beyond its 52-week low. About 1.66 million shares traded.

As of now, Exact Sciences Corporation has a P/S, P/E and P/B values of 22.01, 0 and 10.99 respectively. It has outperformed by 69.88% the S&P500. Craig Hallum set a $28.00 target price on shares of EXACT Sciences and gave the company a "buy" rating in a research note on Monday, March 27th.

The move comes after 6 months positive chart setup for the $5.77 billion company. Market capitalization is just a fancy declare for a comprehensible concept: it is the market value of a company's outstanding shares. The stock increased 6.24% or $2.8 during the last trading session, reaching $47.68. About 259,364 shares traded. Exact Sciences had 25 analyst reports since October 19, 2017 according to SRatingsIntel. It has outperformed by 0.99% the S&P500.

On Wednesday, January 3rd, D Scott Coward sold 1,665 shares of EXACT Sciences stock. Therefore 61% are positive. After $-0.18 actual EPS reported by Exact Sciences Corporation for the previous quarter, Wall Street now forecasts 116.67 % negative EPS growth. The rating was maintained by KeyBanc Capital Markets on Thursday, January 25 with "Buy". William Blair reaffirmed a "buy" rating on shares of EXACT Sciences in a research note on Wednesday, January 10th. The company was maintained on Thursday, October 19 by Bank of America.

TRADEMARK VIOLATION WARNING: "EXACT Sciences (NASDAQ:EXAS) Upgraded by BTIG Research to "Buy" was reported by Macon Daily and is the property of of Macon Daily. On Tuesday, October 31 the firm has "Buy" rating by Canaccord Genuity given. The stock of Exact Sciences Corporation (NASDAQ:EXAS) earned "Buy" rating by Canaccord Genuity on Thursday, July 20. The firm has "Buy" rating given on Wednesday, May 31 by Cowen & Co. The company was downgraded on Wednesday, May 4 by Mizuho. Doheny Asset Management CA bought a new position in EXACT Sciences in the fourth quarter valued at approximately $2,345,000.

On April, 26 WallStreet anticipated Exact Sciences Corporation (NASDAQ:EXAS)'s earnings report, Zacks reports.

I don't see myself missing Grand Slams on objective , says Nadal
For the second-consecutive season, the 36-year-old Federer is skipping the entire claycourt season to be at his best on grass. But at the moment he's really keen on Wimbledon and then the US Open'. "These kind of events I don't see (myself) missing".

ASUS Zenfone Max Pro M1 will be launched exclusively on Flipkart
Futures: Android 8.0 (Oreo), Dual SIM (nano + nano), Fingerprint sensor, Face unlock and 5-magnet speaker, NXP Smart Amp. However, the ZenFone Max Pro M1 was briefly spotted on Asus Indonesia's Instagram page along with its specs sheet.

21st Century Fox Rejected Comcast Offer Over Lack Of Breakup Fee
On Thursday, sources said that some interaction has taken place between Comcast and Sky as far as regulator process is concerned. The filing also noted that Comcast didn't offer Fox a breakup fee in the event the deal didn't pass the regulatory hurdle.

Analysts expected the average price target of $56.91 that is probable to reach in coming one year period. The medical research company reported ($0.18) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.27) by $0.09.

Big Money Sentiment decreased to 0.88 in 2017 Q4. That's change of 0.13, from 2017Q3's 1.01. It increased, as 31 investors sold KLAC shares while 145 reduced holdings. 44 funds bought positions and 70 increased positions. Salem Investment Counselors Inc. lifted its stake in EXACT Sciences by 548.0% in the fourth quarter. The firm owned 185,429 shares of the medical research company's stock after selling 2,902 shares during the period. Parametric Port Assocs Lc holds 0.01% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS) for 144,485 shares.

Bain Capital Investors Llc holds 9.35% of its portfolio in Bright Horizons Family Solutions Inc. for 4.48 million shares. Advisory Services Network LLC now owns 3,350 shares of the medical research company's stock valued at $176,000 after buying an additional 3,300 shares during the period. C Worldwide Grp Holdings A S holds 0.06% or 73,310 shs in its capital. State Street Corporation owns 3.53 million shares or 0.01% of their USA portfolio. Frontier Cap Limited Com accumulated 892,079 shares. Susquehanna Gp Llp has invested 0% in Exact Sciences Corporation (NASDAQ:EXAS).

Since January 2, 2018, it had 0 buys, and 20 insider sales for $24.73 million activity.

Analysts expect Exact Sciences Corporation (NASDAQ:EXAS) to report $-0.39 EPS on April, 26 after the close.They anticipate $0.07 EPS change or 21.88% from last quarter's $-0.32 EPS. On Tuesday, April 10 Carey Thomas D. sold $335,630 worth of Exact Sciences Corporation (NASDAQ:EXAS) or 8,448 shares. 125,402 Exact Sciences Corporation (NASDAQ:EXAS) shares with value of $6.62M were sold by Conroy Kevin T. 2,982 Exact Sciences Corporation (NASDAQ:EXAS) shares with value of $126,252 were sold by Elliott Jeffrey Thomas. The insider Higashi Emiko sold $213,000. Sold All: 17 Reduced: 66 Increased: 79 New Position: 34. Funds hold 92.48 million shares thus 1.24% less from 2017Q3's 93.65 million shares. The British Columbia - Canada-based British Columbia Management has invested 0.05% in KLA-Tencor Corporation (NASDAQ:KLAC). Eagle Asset Management Incorporated invested in 1.79M shares. Wasatch Advsrs reported 0.89% stake. California Public Employees Retirement holds 0% of its portfolio in Ampio Pharmaceuticals, Inc. Morgan Stanley accumulated 7,254 shares. Cleararc Incorporated reported 3,980 shares or 0.06% of all its holdings. Brandes Prtnrs Limited Partnership owns 0% invested in Ampio Pharmaceuticals, Inc. Southport Limited Liability Corporation owns 9,000 shares for 1.16% of their portfolio. Parkside Bancorporation holds 0% or 55 shares. Glg Ltd Liability Company has 8,100 shares for 0.06% of their portfolio. Oppenheimer And Inc reported 20,000 shares or 0% of all its holdings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.